Publication: Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy
Program
Authors
Authors
Bozbay, Mehmet
Uyarel, Huseyin
Avsar, Sahin
Oz, Ahmet
Keskin, Muhammed
Tanik, Veysel Ozan
Bakhshaliyev, NIJAD
Ugur, Murat
Pehlivanoglu, Seckin
Eren, Mehmet
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Background: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.
Description
Source:
Keywords:
Keywords
Citation
Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O. , Bakhshaliyev N., Ugur M., Pehlivanoglu S., Eren M., -Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy-, JOURNAL OF CRITICAL CARE, cilt.30, ss.1179-1183, 2015